DiscoverWhat's NextAntibody discovery with LabGenius' James Field
Antibody discovery with LabGenius' James Field

Antibody discovery with LabGenius' James Field

Update: 2024-06-06
Share

Description

What do synthetic biology, machine learning and robotics have in common? James Field, CEO and founder of LabGenius, explains how his company is integrating bleeding-edge technologies from across these fields to discover the next-generation therapeutic antibodies. And change the way we approach drug discovery.  


Find out more about Labgenius here and follow them on LinkedIn

Find Balderton Capital here and follow us on LinkedIn 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Antibody discovery with LabGenius' James Field

Antibody discovery with LabGenius' James Field

Balderton Capital